Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation.
Between June 1981 and May 1990, 11 patients with recurrent locally advanced nasopharyngeal carcinoma were treated with heavy charged particle radiation at Lawrence Berkeley Laboratory. All patients had previously undergone full course radiotherapy to a median dose of 70.2 Gy [range 61-81 Gy]. Median time to recurrence was 18.2 months. At the time of heavy charged particle radiotherapy treatment, all had evidence of invasion of the base of skull and 7 of 11 had cranial nerve deficits. None of the patients were candidates for brachytherapy because of tumor extent or poor geometry. The tumor histology was squamous cell carcinoma in 10 patients and lymphoepithelioma in one patient. Ten of the 11 patients had received chemotherapy prior to re-irradiation. The heavy charged particle tumor dose delivered ranged from 31.80 GyE to 62.30 GyE (average 50.25 GyE, median 50 GyE). Local control was achieved in 45%. Median survival was 42 months. Actuarial survival was 59% at 3 years and 31% at 5 years (Kaplan-Meier). There were no fatal complications. The results in treating locally advanced recurrent nasopharyngeal carcinoma with heavy charged particles appear superior to those reported by others using photon therapy.
Feehan
P E
PE
Department of Radiation Oncology, University of California San Francisco 94143.
Castro
J R
JR
Phillips
T L
TL
Petti
P
P
Collier
J M
JM
Daftari
I
I
Fu
K
K
D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000532:radiotherapy*; D006371:Helium; D007477:Ions; D009303:Nasopharyngeal Neoplasms / Q000453:epidemiology / Q000532:radiotherapy*; D009356:Neon; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000532:radiotherapy*; D012189:Retrospective Studies
D007477:Ions; D006371:Helium; D009356:Neon